Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will ...
A new artificial intelligence (AI) method called BioPathNet helps researchers systematically search large biological data ...
Palantir stock has strong cash flows, though cash flow margins dipped on a YoY and QoQ basis. Q3 operating cash flows grew by ...
CAS, a division of the American Chemical Society specializing in scientific knowledge management, announces complete functionality for CAS IP Findertm, powered by STNtm. CAS STNext® customers can now ...
Axsome Therapeutics focuses on CNS drug development as nasdaq today reflects activity across biopharmaceutical companies.
Atlassian (TEAM) stock is down 25% on AI fears—see why its moat, switching costs, and 30% growth outlook may signal upside.
Enhancing link prediction in biomedical knowledge graphs with BioPathNet. Nature Biomedical Engineering. DOI: 10.1038/s41551-025-01598-z ...
Business.com on MSN
2026 small business AI outlook report
U.S. small businesses are investing in AI technology, up from 36% in 2023, and 30% of employees now use AI daily.
An assistant professor of computing science at the U of A’s Augustana campus has successfully identified common bugs in ...
Challenging long-held assumptions, Aarhus University researchers have demonstrated that the protein building blocks essential ...
ACI Worldwide (NASDAQ:ACIW) delivers global payment software solutions as part of broader discussions around the nasdaq 100 ...
How Time Flies is a daily feature looking back at Pantagraph archives to revisit what was happening in our community and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results